Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Pharmacol Toxicol ; 85(5): 221-9, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10608484

ABSTRACT

The ingestion of large quantities of glycyrrhizin, whether as a drug or a sweetener, is known, in susceptible subjects, to induce a syndrome similar to hypermineralcorticoidism, with bouts of hypertension, hypokaliaemia and rabdomyolysis, sometimes associated with severe renal failure and hypokaliaemia-induced arrythmias. Glycyrrhizin is also known to isomerize into the glycyrrhetic (or glycyrrhetinic) acids 18alpha- and 18beta-. In previous works, we reported that these metabolites cause bouts of hypertension and reduction in diuresis at low doses in the rat. In particular, the alpha isomer causes significant elimination of the calcium ion in the urine. The present findings confirm that 18alpha-glycyrrhetic acid is more toxic than either glycyrrhizin or the beta isomer. Histopathological study of tissue samples taken from rats treated with the alpha isomer also reveal selective damage to the myocardium with oedema, myolysis, apoptosis and blistering of the sarcoplasm. These effects begin to appear in the course of subchronic treatment, they manifest themselves in acute treatment and correlate closely with the electrocardiographic changes recorded in rats acutely treated with 18alpha-glycyrrhetic acid.


Subject(s)
Glycyrrhetinic Acid/toxicity , Glycyrrhizic Acid/toxicity , Myocardium/pathology , Papillary Muscles/drug effects , Animals , Electrocardiography/drug effects , Female , Kidney/drug effects , Kidney/pathology , Papillary Muscles/pathology , Random Allocation , Rats , Rats, Sprague-Dawley , Stereoisomerism , Time Factors
2.
J Antimicrob Chemother ; 40(1): 19-25, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9249200

ABSTRACT

This paper reports the findings obtained using two new compounds belonging to the 5-nitroimidazole family: sulphuridazole (V1) and sulphonidazole (V2). We first assessed their antimicrobial activity on Clostridia spp. and then extended the study to Gram-positive and Gram-negative aerobic microorganisms and to Candida albicans. Their MICs were compared with those of metronidazole. The findings show that the antibacterial and antimycotic activity of sulphonidazole is greater than that of sulphuridazole, while metronidazole is not active against any aerobic organism. It also emerges that the NO2 group is indispensable for all the microorganisms assayed and that sulphuridazole and sulphonidazole are the first two 5-nitroimidazoles active against C. albicans. The redox potentials of the 5-nitroimidozoles studied suggest that their action mechanism is mainly based on redox processes.


Subject(s)
Anti-Infective Agents/pharmacology , Bacteria/drug effects , Nitroimidazoles/pharmacology , Sulfones/pharmacology , Anti-Bacterial Agents , Candida/drug effects , Clostridium/drug effects , Electrochemistry/methods , Escherichia coli/drug effects , Metronidazole/pharmacology , Microbial Sensitivity Tests , Nitroimidazoles/chemistry , Nitroimidazoles/metabolism , Oxidation-Reduction
3.
Anticancer Res ; 17(6D): 4339-44, 1997.
Article in English | MEDLINE | ID: mdl-9494530

ABSTRACT

The most widely-known anti-tumor drugs often induce marked immunosuppression which can give rise to one or more sepses. Anti-infection measures immediately applied can sometimes prove largely ineffective or even useless, the patient dying not as a result of the spread of the tumour but as a direct consequence of opportunistic infection. We postulate that antagonism between anti-tumour and antimicrobial drugs may also play an important part in this. By way of illustration of this hypothesis, we have studied the action of a number of known inhibitors of peptidoglycan synthesis and of DNA-gyrases on certain strains of Gram-positive and Gram-negative microorganisms cultured in medium containing various concentrations of some of the best-known anti-tumour antimetabolites. The experimental data show that antimicrobial and anti-tumour drugs can sometimes induce synergic or indifferent chemotherapeutic interactions with many bacteria, while in others the effect is antagonistic. In practice, the action of the drugs could lead to bacterial selectivity, which, in conjunction with immunosuppression and the presence of resistant strains, could favour the evolution of opportunistic infection.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antineoplastic Agents/pharmacology , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Opportunistic Infections/microbiology , Aztreonam/pharmacology , Cilastatin/pharmacology , Cilastatin, Imipenem Drug Combination , Drug Antagonism , Drug Combinations , Drug Synergism , Drug Therapy, Combination/pharmacology , Enterococcus faecalis/drug effects , Escherichia coli/drug effects , Gram-Negative Bacteria/growth & development , Gram-Positive Bacteria/growth & development , Humans , Imipenem/pharmacology , Klebsiella pneumoniae/drug effects , Microbial Sensitivity Tests , Pseudomonas aeruginosa/drug effects , Serratia marcescens/drug effects , Staphylococcus aureus/drug effects , Teicoplanin/pharmacology
4.
Anticancer Res ; 16(5A): 2673-5, 1996.
Article in English | MEDLINE | ID: mdl-8917368

ABSTRACT

Substances like imidazoles, benzimidazoles and also quinolines, whose chemical structure includes a heterocyclic nitrogen, are known to interfere with the microsomal oxidation and, in some cases, with the metabolism of drugs. Since chloroquine and primaquine exert this effect in vivo and in vitro, we studied the influence of other antimalarials (quinine and mepacrine) in mice with induced Ehrlich ascites tumour (EAT) to find out whether variations in oxygen consumption affected the course of the disease. In vitro data, obtained by a polarographic technique, indicate that primaquine and, in particular, mepacrine increase EAT-cell oxygen consumption, while in vivo data, obtained in mice injected with an inoculum of about 1 x 10(6) tumour cells per mouse, show that both drugs, but notably mepacrine, accelerate tumour growth, as monitored by Cox's statistical method for body weight, and lead to earlier death. In cases of existing neoplasia, therefore, the potentially toxic effects of certain antimalarials must be borne in mind.


Subject(s)
Antimalarials/pharmacology , Carcinoma, Ehrlich Tumor/metabolism , Oxygen Consumption/drug effects , Animals , Chloroquine/pharmacology , Disease Progression , Female , Mice , Neoplasm Transplantation , Primaquine/pharmacology , Quinacrine/pharmacology , Quinine/pharmacology
5.
Chemotherapy ; 41(5): 337-44, 1995.
Article in English | MEDLINE | ID: mdl-8521735

ABSTRACT

The in vitro activity of a chemotherapeutic agent, sulfimidazole (SIZ), obtained by combining two molecules belonging to groups of extremely different antibacterial drugs, p-aminobenzene sulfonamide and a derivative with a 5-nitroimidazole ring, was studied. In association with trimethoprim, SIZ induces an intense synergistic antibacterial effect on gram-negative and gram-positive aerobic microorganisms and Clostridia. The results show that, in SIZ, the activity of each starting molecule remains unchanged providing that its structure-action relationship is kept intact.


Subject(s)
Anti-Bacterial Agents/pharmacology , Clostridium/drug effects , Escherichia coli/drug effects , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Nitroimidazoles/pharmacology , Sulfonamides/pharmacology , Trimethoprim/pharmacology , Drug Synergism , In Vitro Techniques , Time Factors
6.
In Vivo ; 9(3): 183-6, 1995.
Article in English | MEDLINE | ID: mdl-8562878

ABSTRACT

It has been demonstrated that 18 alpha-glycyrrhetinic acid, 18 beta-glycyrrhetinic acid and glycyrrhizin effectively inhibit the inception and growth of skin tumours. Moreover, glycyrrhizin and its aglycone act on the growth and differentiation of mouse melanoma cells in culture. In this study we investigated the effect of glycyrrhizin, 18 alpha- and 18 beta-glycyrrhetinic acids on the evolution of Ehrlich ascites tumour in mice. A prolonged glycyrrhizin treatment proved to be effective in modifying the animals' survival pattern.


Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Ehrlich Tumor/drug therapy , Glycyrrhetinic Acid/analogs & derivatives , Animals , Carcinoma, Ehrlich Tumor/pathology , Cell Division/drug effects , Cell Respiration/drug effects , Female , Glycyrrhetinic Acid/pharmacology , Glycyrrhizic Acid , Gum Arabic/pharmacology , Mice
7.
In Vivo ; 8(3): 317-20, 1994.
Article in English | MEDLINE | ID: mdl-7803711

ABSTRACT

Recent clinical and toxicological studies have investigated the mineralcorticoid-like and hypertensive effects of liquorice, and we therefore set out to identify the active component responsible for these effects. We conducted a 30-day comparative analysis of glycyrrhizin and 18 beta-glycyrrhetinic acid and found that the latter causes significant variations both in systolic blood pressure and in the excretion in the urine of Ca++. The effects were fully reversible on suspension of treatment.


Subject(s)
Blood Pressure/drug effects , Diuresis/drug effects , Glycyrrhetinic Acid/analogs & derivatives , Glycyrrhetinic Acid/pharmacology , Administration, Oral , Animals , Calcium/urine , Glycyrrhizic Acid , Male , Rats , Rats, Sprague-Dawley , Time Factors
8.
Pharmacol Res ; 25(4): 373-81, 1992.
Article in English | MEDLINE | ID: mdl-1409249

ABSTRACT

Sulphimidazole is a new sulphonamide belonging to the class of intestinal sulphonamides and characterized by the fact that it is active even in vitro. It has the heterocyclic ring of 5-nitroimidazoles on amidic nitrogen. Its antibacterial activity is similar to that of the classical sulphonamides but differs in that it also combats certain anaerobic bacteria such as Clostridium botulinum. This effect is completely absent in the case of sulphadiazine and sulphamethoxazole. Also, since p-amino-benzene-sulphonamide is present in the molecule, the drug acts in synergism with trimethoprim against certain aerobic or facultative strains of enteric pathogens.


Subject(s)
Bacteria/drug effects , Nitroimidazoles/pharmacology , Sulfonamides/pharmacology , Trimethoprim/pharmacology , Bacteria, Anaerobic/drug effects , Clostridium/drug effects , Culture Media , Drug Synergism , Enterobacteriaceae/drug effects , Microbial Sensitivity Tests , Pseudomonas aeruginosa/drug effects , Staphylococcus aureus/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...